Novavax, Inc. NVAX
10.78 USD +1.00 (+10.22%)
At closeNov 9, 2026, 7:15 AM EST
10.71 -0.07 -0.65%
Pre-market · Nov 9, 7:15 AM ET
10.00 Day range 10.93
6.20 52-week range 13.39
- YTD
- +60.42%
- 1 year
- +44.89%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.12B | 682.16M | 983.71M | 1.98B | 1.15B | |
| 1.12B | 682.16M | 983.71M | 1.98B | 1.15B | |
| 73.04M | 202.74M | 343.77M | 902.64M | 0 | |
| 1.05B | 479.42M | 639.94M | 1.08B | 1.15B | |
| 597.64M | 728.35M | 1.21B | 1.72B | 2.83B | |
| 342.32M | 391.17M | 737.50M | 1.24B | 2.53B | |
| 157.48M | 337.19M | 468.95M | 488.69M | 298.36M | |
| 452.80M | -248.93M | -566.51M | -644.74M | -1.69B | |
| 22.55M | 20.07M | 14.42M | 19.88M | 21.13M | |
| 1.86M | 10.88M | 2.03M | 4.29M | 29.21M | |
| 440.30M | -187.50M | -545.06M | -657.94M | -1.74B | |
| 440.30M | -187.50M | -545.06M | -657.94M | -1.74B | |
| 440.30M | -187.50M | -545.06M | -657.94M | -1.74B | |
| 440.30M | -187.50M | -545.06M | -657.94M | -1.74B | |
| 2.72 | -1.23 | -5.41 | -8.42 | -23.44 | |
| 2.72 | -1.23 | -5.41 | -8.42 | -23.44 | |
| 2.72 | -1.23 | -5.41 | -8.42 | -23.44 | |
| 464.71M | -156.54M | -528.62M | -633.77M | -1.69B | |
| 464.71M | -156.54M | -528.62M | -633.77M | -1.69B | |
| 161.99M | 152.19M | 100.77M | 78.18M | 74.40M | |
| 173.10M | 152.19M | 100.77M | 78.18M | 74.40M |